STOCK TITAN
  1. Home
  2. Financials
  3. CATG

Leverage Shares 2X Long CAT Daily ETF Financials

CATG
Source SEC Filings (10-K/10-Q) Updated Aug 31, 2025 Currency USD FYE August

This page shows Leverage Shares 2X Long CAT Daily ETF (CATG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 58 / 100
Financial Profile 58/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Leverage Shares 2X Long CAT Daily ETF's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
0

Leverage Shares 2X Long CAT Daily ETF's revenue declined 12.1% year-over-year, from $3.0M to $2.6M. This contraction results in a growth score of 0/100.

Leverage
98

Leverage Shares 2X Long CAT Daily ETF carries a low D/E ratio of -1.21, meaning only $-1.21 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
0

Leverage Shares 2X Long CAT Daily ETF's current ratio of 0.10 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Neutral
5/9

Leverage Shares 2X Long CAT Daily ETF passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.33x

For every $1 of reported earnings, Leverage Shares 2X Long CAT Daily ETF generates $0.33 in operating cash flow (-$2.6M OCF vs -$8.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.6M
YoY-12.1%
5Y CAGR-34.1%

Leverage Shares 2X Long CAT Daily ETF generated $2.6M in revenue in fiscal year 2025. This represents a decrease of 12.1% from the prior year.

EBITDA
N/A
Net Income
-$8.0M
YoY+8.2%

Leverage Shares 2X Long CAT Daily ETF reported -$8.0M in net income in fiscal year 2025. This represents an increase of 8.2% from the prior year.

EPS (Diluted)
$-3.16
YoY-89.2%

Leverage Shares 2X Long CAT Daily ETF earned $-3.16 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 89.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$108K
YoY-72.1%
5Y CAGR-47.8%

Leverage Shares 2X Long CAT Daily ETF held $108K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
2M
YoY-61.0%
5Y CAGR-39.4%

Leverage Shares 2X Long CAT Daily ETF had 2M shares outstanding in fiscal year 2025. This represents a decrease of 61.0% from the prior year.

Margins & Returns

Gross Margin
54.2%
YoY+54.2pp
5Y CAGR+3.3pp

Leverage Shares 2X Long CAT Daily ETF's gross margin was 54.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 54.2 percentage points from the prior year.

Operating Margin
N/A
Net Margin
-302.2%
YoY-12.9pp
5Y CAGR-350.3pp

Leverage Shares 2X Long CAT Daily ETF's net profit margin was -302.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 12.9 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CATG Income Statement

Metric Q4'25 Q4'24 Q1'13 Q4'12 Q3'12 Q2'12 Q1'12 Q4'11
Revenue N/A N/A $11.6M+9.2% $10.7M+5.1% $10.2M-7.3% $11.0M+5.1% $10.4M+65.9% $6.3M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A $3.0M
Gross Profit N/A N/A $3.9M-27.9% $5.4M+17.3% $4.6M-10.7% $5.2M+61.6% $3.2M-2.3% $3.3M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A $481K-67.6% $1.5M+180.6% $528K-15.6% $626K+24.1% $505K+665.0% $66K
Operating Income N/A N/A $3.4M-12.9% $3.9M-3.9% $4.1M-10.1% $4.5M+68.6% $2.7M-16.1% $3.2M
Interest Expense N/A N/A $822K+851.3% $86K-95.9% $2.1M+0.1% $2.1M+50.7% $1.4M N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A $2.6M-31.9% $3.9M+92.2% $2.0M-18.4% $2.5M+83.7% $1.3M-58.4% $3.2M
EPS (Diluted) N/A N/A $0.09 N/A $0.07-12.5% $0.08+100.0% $0.04-63.6% $0.11

CATG Balance Sheet

Metric Q4'25 Q4'24 Q1'13 Q4'12 Q3'12 Q2'12 Q1'12 Q4'11
Total Assets $3.0M-25.2% $4.0M-97.2% $142.9M-13.3% $164.9M+19.8% $137.6M-1.1% $139.2M-5.5% $147.3M+161.9% $56.3M
Current Assets $413K-66.7% $1.2M-89.5% $11.8M-65.8% $34.5M+185.8% $12.1M+4.5% $11.5M-22.4% $14.9M+6.6% $14.0M
Cash & Equivalents $108K-72.1% $386K-95.7% $9.0M-70.3% $30.4M+237.4% $9.0M+38.8% $6.5M-28.1% $9.0M-27.1% $12.4M
Inventory N/A N/A N/A N/A $72K+22.5% $58K+59.0% $37K-53.8% $79K
Accounts Receivable $210K-0.5% $211K N/A N/A N/A N/A N/A N/A
Goodwill $349K0.0% $349K N/A N/A N/A N/A N/A N/A
Total Liabilities $17.0M-38.3% $27.5M-68.4% $87.1M-22.4% $112.2M+25.2% $89.6M-3.5% $92.9M-10.7% $104.0M+490.6% $17.6M
Current Liabilities $4.2M-82.3% $23.5M-61.9% $61.7M-28.5% $86.4M+34.0% $64.4M-5.7% $68.4M-10.8% $76.6M+335.0% $17.6M
Long-Term Debt N/A N/A $11.2M+1.0% $11.0M N/A N/A N/A N/A
Total Equity -$14.0M+40.5% -$23.5M-142.1% $55.8M+6.0% $52.6M+9.7% $48.0M+3.7% $46.3M+6.8% $43.3M+12.1% $38.6M
Retained Earnings -$32.0M-35.9% -$23.5M-144.9% $52.4M+5.3% $49.7M+10.0% $45.2M+4.6% $43.2M+6.0% $40.8M+11.1% $36.7M

CATG Cash Flow Statement

Metric Q4'25 Q4'24 Q1'13 Q4'12 Q3'12 Q2'12 Q1'12 Q4'11
Operating Cash Flow N/A N/A -$4.5M-116.3% $27.6M+1001.2% $2.5M+259.8% -$1.6M+32.2% -$2.3M-13.6% -$2.0M
Capital Expenditures N/A N/A $589K-13.4% $681K+375.9% -$247K-331.9% $106K-74.9% $424K+1609.1% $25K
Free Cash Flow N/A N/A -$5.1M-118.9% $26.9M+1091.4% $2.3M+234.9% -$1.7M+38.8% -$2.7M-32.8% -$2.1M
Investing Cash Flow N/A N/A N/A N/A $247K+331.9% -$106K+74.9% -$424K+47.3% -$803K
Financing Cash Flow N/A N/A N/A N/A -$168K+83.2% -$1.0M+69.9% -$3.3M N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CATG Financial Ratios

Metric Q4'25 Q4'24 Q1'13 Q4'12 Q3'12 Q2'12 Q1'12 Q4'11
Gross Margin N/A N/A 33.4%-17.2pp 50.6%+5.3pp 45.4%-1.7pp 47.1%+16.5pp 30.6%-21.4pp 52.0%
Operating Margin N/A N/A 29.3%-7.4pp 36.8%-3.4pp 40.2%-1.2pp 41.4%+15.6pp 25.8%-25.2pp 51.0%
Net Margin N/A N/A 22.5%-13.6pp 36.1%+16.4pp 19.7%-2.7pp 22.4%+9.6pp 12.8%-38.3pp 51.1%
Return on Equity N/A N/A 4.7%-2.6pp 7.3%+3.1pp 4.2%-1.1pp 5.3%+2.2pp 3.1%-5.2pp 8.3%
Return on Assets N/A N/A 1.8%-0.5pp 2.3%+0.9pp 1.5%-0.3pp 1.8%+0.9pp 0.9%-4.8pp 5.7%
Current Ratio 0.10+0.0 0.05-0.1 0.19-0.2 0.40+0.2 0.19+0.0 0.17-0.0 0.19-0.6 0.79
Debt-to-Equity -1.21-0.0 -1.17-1.4 0.200.0 0.21-1.7 1.87-0.1 2.01-0.4 2.40+1.9 0.46
FCF Margin N/A N/A -43.7%-295.9pp 252.2%+229.9pp 22.2%+37.5pp -15.3%+10.9pp -26.2%+6.5pp -32.8%

Note: Shareholder equity is negative (-$14.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.10), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Datametrex Ai Li DTMXF
$4.5M
Xalles Holdings XALL
$1.3M
Seatech Ventures SEAV
$4.2M
NFT Technologies NFTFF
$696K
Signature Devices Inc SDVI
$675K

Frequently Asked Questions

Leverage Shares 2X Long CAT Daily ETF (CATG) reported $2.6M in total revenue for fiscal year 2025. This represents a -12.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Leverage Shares 2X Long CAT Daily ETF (CATG) revenue declined by 12.1% year-over-year, from $3.0M to $2.6M in fiscal year 2025.

No, Leverage Shares 2X Long CAT Daily ETF (CATG) reported a net income of -$8.0M in fiscal year 2025, with a net profit margin of -302.2%.

Leverage Shares 2X Long CAT Daily ETF (CATG) reported diluted earnings per share of $-3.16 for fiscal year 2025. This represents a -89.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a gross margin of 54.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a net profit margin of -302.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Leverage Shares 2X Long CAT Daily ETF (CATG) generated -$2.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Leverage Shares 2X Long CAT Daily ETF (CATG) had $3.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Leverage Shares 2X Long CAT Daily ETF (CATG) had 2M shares outstanding as of fiscal year 2025.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a current ratio of 0.10 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a debt-to-equity ratio of -1.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a return on assets of -267.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Leverage Shares 2X Long CAT Daily ETF (CATG) had $108K in cash against an annual operating cash burn of $2.6M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Leverage Shares 2X Long CAT Daily ETF (CATG) has negative shareholder equity of -$14.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Leverage Shares 2X Long CAT Daily ETF (CATG) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Leverage Shares 2X Long CAT Daily ETF (CATG) has an earnings quality ratio of 0.33x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Leverage Shares 2X Long CAT Daily ETF (CATG) scores 58 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top